Navigation Links
Scientists, physicians present latest findings in 'personalized' cancer treatment and prevention
Date:9/10/2007

PHILADELPHIA Scientists and clinicians from around the world will gather in Atlanta, Georgia next week at the American Association for Cancer Researchs second International Conference on Molecular Diagnostics in Cancer Therapeutic Development. The conference is subtitled Maximizing Opportunities for Personalized Treatment, which reflects the potential of molecular diagnostics to provide new strategies for tailoring therapies to fit the needs of each cancer patients unique biology.

Sessions will include discussions on the use of biomarkers blood-borne molecules that indicate the presence of cancer in clinical practice and new drug development, advanced imaging technologies for diagnosis, and the application of proteomics in personalized medicine. Novel findings to be reported at the conference include:

  • Case studies that report how clinicians are already bridging the gap between basic cancer biology and personalized clinical care. Researchers present examples of how they fine-tuned the treatment of a number of different cancer types, including lung and ovarian, based on the genetic profile of the patients tumors.

  • A new acoustic sensor device that could make it possible to screen for multiple cancer biomarkers during a routine doctors visit.

  • A sensitive blood test for early-stage liver cancer that detects a gene altered by the molecular processes that lead to cancer.

  • A blood-borne protein, present in 99 percent of lung cancer patients tested, could provide a target for a simple blood test for the disease.

As genetic, proteomic, imaging, and other new technologies become more sophisticated and our knowledge of tumor biology and signaling pathways advances, so too does our ability to molecularly characterize individual tumors and identify germline determinants of patient prognosis and response, said David Sidransky, M.D., meeting chairperson and professor of Otolaryngology - Head and Neck Surgery, Oncology, Pathology, Urology, and Cellular and Molecular Medicine at Johns Hopkins University School of Medicine and director, Head and Neck Cancer Research at The Johns Hopkins Hospital.

This new era of personalized medicine has brought with it great opportunities to enhance cancer drug development and improve patient care, Dr. Sidransky said. However, in order to harness this potential and maximize these opportunities, it is essential that there be an ongoing exchange of new ideas and information.

In addition to symposia and poster sessions, the conference will include a keynote lecture by Victor E. Velculescu, M.D., Ph.D., assistant professor in the Department of Oncology at Johns Hopkins Universitys Sidney Kimmel Comprehensive Cancer Center. Dr. Velculescu, a cancer genetics researcher, presents an address entitled Blueprint of the Breast and Colorectal Cancer Genomes.


'/>"/>

Contact: Greg Lester
lester@aacr.org
267-646-0554
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. Male Contraception: Discovery Stirring Interest Among Scientists, Drug Developers
2. Startling Expose – Physicians Often Have No Regular Source Of Health Car
3. IMA to create database on physicians
4. "Make AIDS Therapy affordable" - Physicians demand
5. Physicians Consider Self-Prescribing Ethical
6. Guide for physicians launched to help them identify alcohol disorders
7. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
8. Physicians Need To Treat Patients With Respect For Treatment To Be Effective
9. Resident Physicians Need More Preparations To Treat Patients From Different Cultures
10. Physicians To Discuss Ways To Save Premature Babies From RSV
11. Physicians should encourage US women to breastfeed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... ... of the Best Places to Work in the Research Triangle for 2017. , ... nominated, a company had to meet a threshold in employee participation--a percentage that ...
(Date:9/20/2017)... ... 2017 , ... Demand generation pioneer True Influence has announced ... The Marketing Tech Conference October 2–4, at the Hynes Convention Center in Boston, ... representing such thought-leading companies as JP Morgan Chase, GE Digital, and Dun & ...
(Date:9/20/2017)... ... ... In just a short time since going on sale on Wal-Mart Stores-owned ... trying the product for the first time, and others who had already been using ... Moore, MD, for everyone from athletes at risk from multiple concussions to elderly consumers ...
(Date:9/20/2017)... ... September 20, 2017 , ... Health & Safety Institute (HSI) ... HAZWOPER 8-, 24- and 40-Hour courses from now until November 30, 2017 to assist ... offering these discounted prices to all businesses and government agencies – whether or not ...
(Date:9/20/2017)... ... September 20, 2017 , ... Houston, Texas, investment firm ... Friday, September 8, and Monday, September 11, off work and rolled up their sleeves ... before heading to local homes to start the process of rebuilding. , CORDA founder ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... IRVING, Texas , Sept. 7, 2017 /PRNewswire/ ... molecular science focused on fulfilling the promise of ... that further validate the benefits of its molecular ... Each study utilized comprehensive genomic profiling plus (CGP+) ... each individual patient,s tumor on a molecular level, ...
(Date:9/6/2017)... ANTONIO , Sept. 6, 2017  Robert G. ... a Pinnacle Professional Member in recognition of his contributions ... Szewc serves as a Nephrologist at the practice of ... emergency medicine, kidney care and hypertension solutions. He has ... 20 years of career experience, as well as expertise ...
(Date:9/6/2017)... Eli Lilly and Company (NYSE: ... for galcanezumab and lasmiditan, two investigational treatments for migraine, ... (IHC) taking place Sept. 7-10 in Vancouver ... long-term data from an open-label study evaluating the safety ... and 240 mg) for the prevention of migraine. Galcanezumab ...
Breaking Medicine Technology: